• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANGIODYNAMICS 400 MICRON FIBER PROCEDURE KIT; VENACURE ENDOVENOUS LASER TREATMENT FIBER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANGIODYNAMICS 400 MICRON FIBER PROCEDURE KIT; VENACURE ENDOVENOUS LASER TREATMENT FIBER Back to Search Results
Catalog Number EVLTPVAK
Device Problem Fracture (1260)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/28/2023
Event Type  malfunction  
Manufacturer Narrative
The reported device has been returned to the manufacturer and an investigation into the root cause for event is currently in progress.The results of the investigation will be sent via a follow up medwatch.Reference (b)(4).
 
Event Description
When opening a pvak -- 400 micron fiber procedure kit for a procedure, it was noted the fiber was broken.A new of the same device was opened and used to complete the procedure.The patient did not experience any adverse effects, harm, or require medical intervention because of this incident.
 
Manufacturer Narrative
Returned for evaluation was one (1) pvak evlt fiber.A visual inspection noted that the fiber had one fracture; it was located at 39mm from the distal tip.Engineer investigation: it is anticipated that there may be some material variability in the fiber glass core which can impact the resultant fiber strength.All fiber material is subjected to an in-process stress test when produced by the vendor to ensure the fiber material can withstand a minimum amount of stress regardless of any material variability.When packaged, the fiber assemblies are coiled to a specific diameter to ensure any stress due to the coiled configuration is not excessive and should not adversely affect the strength of the fiber assembly for its labelled shelf life.This break appears to have occurred under a low level of stress and there are no obvious signs of any mishandling that could have contributed to the failure.It is believed the root cause of this break is most likely due to material variability in the fiber glass core which resulted in a fracture while the fiber was packaged in a coiled configuration which does place a degree of stress on the fiber core.At the vendor facility, during the manufacturing process, fibers are repeatedly bent and coiled and there is a final visual inspection performed with a hene laser to check the entire fiber length for defects prior to shipment.During the packaging step, the fibers are inspected for damage.Potential root cause is handling damage after leaving angiodynamics facility.The customer's reported complaint description of fiber fractured was confirmed.Based on the reported complaint description the root cause for the fiber fracture is likely due to a material variability in the fiber glass core and handling of fiber device during shipping/transit/unpacking.A review of the device history records was performed for the indicated lots for any deviations related to the reported failure mode of the complaint.  the review confirms that the lots met all material, assembly and performance specifications; i.E.No ncr associated with reported failure mode.Labeling review: the directions for use which is supplied to the end user with the reported catalog number contains the following statement "prior to and during use, avoid damaging the fiber by striking, stressing or excessive bending.Do not coil the fiber tighter than a radius of 60mm".A review of the angiodynamics complaint system noted no adverse trends for this complaint type and product family.This type of complaint will continue to be monitored for trends.Reference (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
400 MICRON FIBER PROCEDURE KIT
Type of Device
VENACURE ENDOVENOUS LASER TREATMENT FIBER
Manufacturer (Section D)
ANGIODYNAMICS
603 queensbury avenue
queensbury NY 12804
Manufacturer (Section G)
ANGIODYNAMICS
603 queensbury avenue
queensbury NY 12804
Manufacturer Contact
alexandra invencio
26 forest street
marlborough, MA 01752
5086587990
MDR Report Key16771831
MDR Text Key313818223
Report Number1319211-2023-00032
Device Sequence Number1
Product Code GEX
UDI-Device IdentifierH787EVLTPVAK5
UDI-PublicH787EVLTPVAK5
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K041957
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 05/03/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberEVLTPVAK
Device Lot Number5761781
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/13/2023
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 03/28/2023
Initial Date FDA Received04/19/2023
Supplement Dates Manufacturer Received04/28/2023
Supplement Dates FDA Received05/03/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/26/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-